Sanofi and As­traZeneca to make 230,000 ad­di­tion­al RSV im­mu­niza­tions avail­able, White House says

RSV vac­cine man­u­fac­tur­ers Sanofi and As­traZeneca will make 230,000 more dos­es of their im­mu­niza­tions for in­fants avail­able be­gin­ning in Jan­u­ary to ad­dress high de­mand, the White House an­nounced Thurs­day.

The an­nounce­ment comes as Biden ad­min­is­tra­tion of­fi­cials met with vac­cine man­u­fac­tur­ers on Wednes­day to dis­cuss ramp­ing up RSV im­mu­niza­tion op­tions for chil­dren this fall as man­u­fac­tur­ers face high­er de­mand than an­tic­i­pat­ed.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER